HomeAI · summaries
Storia in 2 fonti
Praxis sinks on late-stage study fail for seizure pill, halts second trial
On Monday, Praxis disclosed a late-stage failure for its investigational seizure medicine, and the company is pausing enrollment in a second trial while it figures out what to do.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Why Is Praxis Stock Plunging Today - Praxis Precision Medicine (NASDAQ:PRAX)
Praxis Precision Medicines reports mixed Phase 2/3 POWER1 results for vormatrigine, with higher-dose data showing stronger seizure reduction.
- ·
endpoints.news
Praxis sinks on late-stage study fail for seizure pill, halts second trial
On Monday, Praxis disclosed a late-stage failure for its investigational seizure medicine, and the company is pausing enrollment in a second trial while it figures out what to do.